1,755
Views
0
CrossRef citations to date
0
Altmetric
Original Research

The impact of vaccination on the burden of invasive pneumococcal disease from a nationwide surveillance program in Lebanon: an unexpected increase in mortality driven by non-vaccine serotypes

, , ORCID Icon, , , , , , , , , , ORCID Icon, , , , , , , , , , , ORCID Icon, , , , , , , , , , , , , , , , , , , & ORCID Icon show all
Pages 1905-1921 | Received 18 Jun 2022, Accepted 31 Oct 2022, Published online: 17 Nov 2022

References

  • Collaborators GLRI, Blacker B, Khalil IA. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Infect Dis. 2018Nov;18(11):1191–1210. PubMed PMID: 30243584; PubMed Central PMCID: PMCPMC6202443.
  • Bonnave C, Mertens D, Peetermans W, et al. Adult vaccination for pneumococcal disease: a comparison of the national guidelines in Europe. Eur J Clin Microbiol Infect Dis. 2019Apr;384:785–791. PubMed PMID: 30778705; eng
  • CENTERS FOR DISEASE CONTROL AND PREVENTION. Global Pneumococcal Disease and Vaccination 2019 [ updated 27/01/2022; cited 2022 19 OCT 2022]. Available from: https://www.cdc.gov/pneumococcal/global.html
  • Wasserman MD, Perdrizet J, Grant L, et al. Clinical and Economic Burden of Pneumococcal Disease Due to Serotypes Contained in Current and Investigational Pneumococcal Conjugate Vaccines in Children Under Five Years of Age. Infect Dis Ther. 2021Dec;10 4:2701–2720. PubMed PMID: 34633639; PubMed Central PMCID: PMCPMC8503717. eng
  • Croucher NJ, Lochen A, Bentley SD. Pneumococcal Vaccines: Host Interactions, Population Dynamics, and Design Principles. Annu Rev Microbiol. 2018 Sep 8;72(1):521–549. PubMed PMID: 30200849.
  • Nelson AL, Roche AM, Gould JM, et al. Capsule enhances pneumococcal colonization by limiting mucus-mediated clearance. Infect Immun. 2007Jan;751:83–90. PubMed PMID: 17088346; PubMed Central PMCID: PMCPMC1828419
  • Kraicer-Melamed H, O’Donnell S, Quach C. The effectiveness of pneumococcal polysaccharide vaccine 23 (PPV23) in the general population of 50 years of age and older: A systematic review and meta-analysis. Vaccine. 2016 Mar 18;34(13):1540–1550. PubMed PMID: 26899372.
  • Moberley S, Holden J, Tatham DP, et al. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev. CD000422. PubMed PMID: 23440780; PubMed Central PMCID: PMCPMC7045867. 2013 Jan;31(1).
  • Prato R, Fortunato F, Cappelli MG, et al. Effectiveness of the 13-valent pneumococcal conjugate vaccine against adult pneumonia in Italy: a case-control study in a 2-year prospective cohort. BMJ Open. 2018;2018 Mar 25;8(3):e019034. PubMed PMID: 29581200; PubMed Central PMCID: PMCPMC5875676.
  • Feldman C, Anderson R. Recent advances in the epidemiology and prevention of Streptococcus pneumoniae infections. F1000Res. 2020;9:338. PubMed PMID: 32411353; PubMed Central PMCID: PMCPMC7212261. eng.
  • Rodgers GL, Whitney CG, Klugman KP. Triumph of Pneumococcal Conjugate Vaccines: Overcoming a Common Foe. J Infect Dis. 2021;224(Supplement_4):S352–S359.
  • Hanquet G, Krizova P, Valentiner-Branth P, et al. Effect of childhood pneumococcal conjugate vaccination on invasive disease in older adults of 10 European countries: implications for adult vaccination. Thorax. 2019;74(5):473.
  • Geno KA, Gilbert GL, Song JY, et al. Pneumococcal Capsules and Their Types: Past, Present, and Future. Clin Microbiol Rev. 2015Jul;283:871–899. PubMed PMID: 26085553; PubMed Central PMCID: PMCPMC4475641
  • Masomian M, Ahmad Z, Gew LT, et al. Development of Next Generation Streptococcus pneumoniae Vaccines Conferring Broad Protection. Vaccines (Basel). 2020 Mar 17;8(1). PubMed PMID: 32192117; PubMed Central PMCID: PMCPMC7157650.
  • Daniels CC, Rogers PD, Shelton CM. A Review of Pneumococcal Vaccines: Current Polysaccharide Vaccine Recommendations and Future Protein Antigens. J Pediatr Pharmacol Ther. 2016Jan-Feb;21(1):27–35. PubMed PMID: 26997927; PubMed Central PMCID: PMCPMC4778694.
  • Pitsiou GG, Kioumis IP. Pneumococcal vaccination in adults: does it really work? Respir Med. 2011Dec;105(12):1776–1783. PubMed PMID: 21816596.
  • Song JY, Moseley MA, Burton RL, et al. Pneumococcal vaccine and opsonic pneumococcal antibody. J Infect Chemother. 2013Jun;193:412–425. PubMed PMID: 23657429; PubMed Central PMCID: PMCPMC3692352
  • Hurley D, Griffin C, Young M, et al. Safety, Tolerability, and Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine (PCV20) in Adults 60 to 64 Years of Age. Clin infect Dis. 2020 Jul 27. PubMed PMID: 32716500.
  • Peterson JT, Stacey HL, MacNair JE, et al. Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine compared to 13-valent pneumococcal conjugate vaccine in adults >/=65 years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccine. Hum Vaccin Immunother. 2019;15(3):540–548. PubMed PMID: 30427749; PubMed Central PMCID: PMCPMC6605723.
  • Greenberg D, Hoover PA, Vesikari T, et al. Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV15) in healthy infants. Vaccine. 2018 Oct 29;36(45):6883–6891. PubMed PMID: 30244873.
  • McFetridge R, Meulen AS, Folkerth SD, et al. Safety, tolerability, and immunogenicity of 15-valent pneumococcal conjugate vaccine in healthy adults. Vaccine. 2015 Jun 4;33(24):2793–2799. PubMed PMID: 25913828.
  • U.S. Food and Drug Administration. Vaxneuvance. 2021 [cited 2021 Oct 5]. https://www.fda.gov/vaccines-blood-biologics/vaccines/vaxneuvance
  • U.S. Food and Drug Administration. Prevnar 20. 2021 [cited 2021 Oct 5]. https://www.fda.gov/vaccines-blood-biologics/vaccines/prevnar-20
  • Grabenstein JD. Effectiveness and serotype coverage: key criteria for pneumococcal vaccines for adults. Clinical Infectious Diseases. 2012 Jul;55(2):255–258. DOI:10.1093/cid/cis354. PubMed PMID: 22495543.
  • Grabenstein JD, Weber DJ. Pneumococcal serotype diversity among adults in various countries, influenced by pediatric pneumococcal vaccination uptake. Clin infect Dis. 2014Mar;58(6):854–864. PubMed PMID: 24344141.
  • Weinberger DM, Malley R, Lipsitch M. Serotype replacement in disease after pneumococcal vaccination. Lancet. 2011 Dec 3;378(9807):1962–1973. PubMed PMID: 21492929; PubMed Central PMCID: PMCPMC3256741.
  • Liu Z, Nachamkin I, Edelstein PH, et al. Serotype emergence and genotype distribution among macrolide-resistant invasive Streptococcus pneumoniae isolates in the postconjugate vaccine (PCV-7) era. Antimicrob Agents Chemother. 2012Feb;562:743–750. PubMed PMID: 22123697; PubMed Central PMCID: PMCPMC3264211
  • Reslan L, Finianos M, Bitar I, et al. The Emergence of Invasive Streptococcus pneumoniae Serotype 24F in Lebanon: Complete Genome Sequencing Reveals High Virulence and Antimicrobial Resistance Characteristics. Front Microbiol. 2021;12:637813. PubMed PMID: 33746930; PubMed Central PMCID: PMCPMC7967862.
  • Hanna-Wakim R, Chehab H, Mahfouz I, et al. Epidemiologic characteristics, serotypes, and antimicrobial susceptibilities of invasive Streptococcus pneumoniae isolates in a nationwide surveillance study in Lebanon [Research Support, Non-U.S. Gov’t]. Vaccine. 2012;30(Suppl 6):G11–7. PubMed PMID: 23228352.
  • Palmu AA, De Wals P, Toropainen M, et al. Similar impact and replacement disease after pneumococcal conjugate vaccine introduction in hospitalised children with invasive pneumococcal disease in Europe and North America. Vaccine. 2021 Mar 12;39(11):1551–1555. PubMed PMID: 33610373.
  • International LRCAoSC, Labour Organization (ILO); European Union (EU). Labour Force and Household Living Conditions Survey 2020 [cited 2022 19 OCT 2022]. Available from: http://www.cas.gov.lb/images/Publications/Labour%20Force%20and%20Household%20Living%20Conditions%20Survey%202018-2019.pdf
  • CENTERS FOR DISEASE CONTROL AND PREVENTION. Invasive Pneumococcal Disease (IPD) (Streptococcus pneumoniae) 2010 [ updated 16/04/2021; cited 2022 19 OCT 2022]. Available from: https://ndc.services.cdc.gov/case-definitions/invasive-pneumococcal-disease-2010/
  • CLSI. Performance standards for antimicrobial susceptibility testing. 30thed. Wayne PA:Clinical and Laboratory Standards Institute;2020. CLSI supplement M100.
  • Jin P, Kong F, Xiao M, et al. First report of putative Streptococcus pneumoniae serotype 6D among nasopharyngeal isolates from Fijian children. J Infect Dis. 2009 Nov 1;200(9):1375–1380. PubMed PMID: 19803727.
  • Jin P, Xiao M, Kong F, et al. Simple, accurate, serotype-specific PCR assay to differentiate Streptococcus pneumoniae serotypes 6A, 6B, and 6C. J Clin Microbiol. 2009Aug;478:2470–2474. PubMed PMID: 19535528; PubMed Central PMCID: PMCPMC2725661
  • General Assembly of the World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. J Am Coll Dent. 2014 Summer;81(3):14–18. PubMed PMID: 25951678; eng
  • Wagenvoort GH, Sanders EA, Vlaminckx BJ, et al. Sex differences in invasive pneumococcal disease and the impact of pneumococcal conjugate vaccination in the Netherlands, 2004 to 2015. Euro Surveill. 2017 Mar 9;22(10). PubMed PMID: 28300529; PubMed Central PMCID: PMCPMC5356421.
  • de St Maurice A, Schaffner W, Griffin MR, et al. Persistent Sex Disparities in Invasive Pneumococcal Diseases in the Conjugate Vaccine Era. J Infect Dis. 2016 Sep 1;214(5):792–797. PubMed PMID: 27247342; PubMed Central PMCID: PMCPMC4978370.
  • Mokaddas E, Albert MJ. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait. Vaccine. 2012 Dec 31;30(Suppl 6):G37–40. PubMed PMID: 23228356.
  • Al-Sheikh YA, KG L, Mohammed Ali MM, et al. Distribution of serotypes and antibiotic susceptibility patterns among invasive pneumococcal diseases in Saudi Arabia. Ann Lab Med. 2014May;343:210–215. PubMed PMID: 24790908; PubMed Central PMCID: PMCPMC3999319
  • Ktari S, Jmal I, Mroua M, et al. Serotype distribution and antibiotic susceptibility of Streptococcus pneumoniae strains in the south of Tunisia: A five-year study (2012-2016) of pediatric and adult populations. Int J Infect Dis. 2017 Dec;65:110–115. PubMed PMID: 29111412.
  • Al-Jardani A, Al Rashdi A, Al Jaaidi A, et al. Serotype distribution and antibiotic resistance among invasive Streptococcus pneumoniae from Oman post 13-valent vaccine introduction. Int J Infect Dis. 2019 Aug;85:135–140. PubMed PMID: 31150842
  • Cui YA, Patel H, O’Neil WM, et al. Pneumococcal serotype distribution: A snapshot of recent data in pediatric and adult populations around the world. Hum Vaccin Immunother. 2017 Jun 3;13(6):1–13. PubMed PMID: 28125317; PubMed Central PMCID: PMCPMC5489298.
  • Hausdorff WP, Feikin DR, Klugman KP. Epidemiological differences among pneumococcal serotypes. Lancet Infect Dis. 2005Feb;5(2):83–93. PubMed PMID: 15680778
  • Rendi-Wagner P, Georgopoulos A, Kundi M, et al. Prospective surveillance of incidence, serotypes and antimicrobial susceptibility of invasive Streptococcus pneumoniae among hospitalized children in Austria. J Antimicrob Chemother. 2004May;535:826–831. PubMed PMID: 15073163
  • Mokaddas EM, Shibl AM, Elgouhary A, et al. Effect of the introduction of pneumococcal conjugate vaccines on serotype prevalence in Kuwait and Saudi Arabia. Vaccine. 2018 Oct 15;36(43):6442–6448. PubMed PMID: 30194003; eng.
  • Ricketson LJ, Bettinger JA, Sadarangani M, et al. Vaccine effectiveness of the 7-valent and 13-valent pneumococcal conjugate vaccines in Canada: An IMPACT study. Vaccine. 2022;40(19):2733–2740.
  • Bryant KA, Block SL, Baker SA, et al. Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine. Pediatrics. 2010May;1255:866–875. PubMed PMID: 20435707; eng
  • Memish ZA, El-Saed A, Al-Otaibi B, et al. Epidemiology of invasive pneumococcal infection in children aged five years and under in Saudi Arabia: a five-year retrospective surveillance study. Int J Infect Dis. 2010Aug;148:e708–12. PubMed PMID: 20627645
  • Torres A, Blasi F, Dartois N, et al. Which individuals are at increased risk of pneumococcal disease and why? Impact of COPD, asthma, smoking, diabetes, and/or chronic heart disease on community-acquired pneumonia and invasive pneumococcal disease. Thorax. 2015Oct;70 1:984–989. PubMed PMID: 26219979; PubMed Central PMCID: PMCPMC4602259
  • Belman S, Chaguza C, Kumar N, et al. A new perspective on ancient Mitis group streptococcal genetics. Microb Genom. 2022 Feb;8(2). PubMed PMID: 35225216; PubMed Central PMCID: PMCPMC8942026. eng.
  • Cillóniz C, Garcia-Vidal C, Ceccato A, et al. Antimicrobial Resistance Among Streptococcus pneumoniae. Antimicrobial Resistance in the 21st Century. 2018;7:13–38. eng DEP - 20180307.
  • El Moujaber G, Osman M, Rafei R, et al. Molecular mechanisms and epidemiology of resistance in Streptococcus pneumoniae in the Middle East region. J Med Microbiol. 2017Jul;667:847–858. PubMed PMID: 28650313
  • Jamsheer A, Rafay AM, Daoud Z, et al. Results from the Survey of Antibiotic Resistance (SOAR) 2011-13 in the Gulf States. J Antimicrob Chemother. 2016May;71 Suppl 1suppl 1:i45–61. PubMed PMID: 27048582; PubMed Central PMCID: PMCPMC4890347
  • Soyletir G, Altinkanat G, Gur D, et al. Results from the Survey of Antibiotic Resistance (SOAR) 2011–13 in Turkey. J Antimicrob Chemother. 2016May;Suppl 71suppl 1:i71–83. PubMed PMID: 27048584; PubMed Central PMCID: PMCPMC4890354
  • Shibl AM, Memish ZA, Al-Kattan KM. Antibiotic resistance and serotype distribution of invasive pneumococcal diseases before and after introduction of pneumococcal conjugate vaccine in the Kingdom of Saudi Arabia (KSA). Vaccine. 2012 Dec 31;30(Suppl 6):G32–6. PubMed PMID: 23228355.
  • Moghnieh R, Araj GF, Awad L, et al. A compilation of antimicrobial susceptibility data from a network of 13 Lebanese hospitals reflecting the national situation during 2015-2016. Antimicrob Resist Infect Control. 2019;8(1):41. PubMed PMID: 30828445; PubMed Central PMCID: PMCPMC6381724.
  • Chamoun K, Farah M, Araj G, et al. Surveillance of antimicrobial resistance in Lebanese hospitals: retrospective nationwide compiled data. Int J Infect Dis. 2016 May;46:64–70. PubMed PMID: 26996458
  • Lieberthal AS, Carroll AE, Chonmaitree T, et al. The diagnosis and management of acute otitis media. Pediatrics. 2013Mar;1313:e964–99. PubMed PMID: 23439909
  • Metlay JP, Waterer GW, Long AC, et al. Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019 Oct 1;200(7):e45–e67. PubMed PMID: 31573350; PubMed Central PMCID: PMCPMC6812437.
  • Habibian S, Mehrabi-Tavana A, Ahmadi Z, et al. Serotype distribution and antibiotics susceptibility pattern of Streptococcus pneumonia in Iran. Iran Red Crescent Med J. 2013Oct;1510:e8053. PubMed PMID: 24693373; PubMed Central PMCID: PMCPMC3950785
  • Buchy P, Ascioglu S, Buisson Y, et al. Impact of vaccines on antimicrobial resistance. Int J Infect Dis. 2020 Jan;90:188–196. PubMed PMID: 31622674